February 2026

• Wrapping Up 2025 Legislation and Kicking Off 2026 With New Health Policy Priorities
• 5 Trends to Watch This Year
• From Policy to Practice: PBM Reform, TrumpRx, and Global Drug Development

April 2026

• Pricing Reforms, Regulatory Shifts, and Global Market Reactions to Most Favored Nation
• Early Global Responses to MFN Signal Shifts in Pricing and Access

May 2026

• Most-Favored-Nation Pricing Expands, Reshaping Global Access and Market Dynamics

June 2026

• ISPOR 2026: Navigating the Interconnections Among Policy, Access, and Value

July 2026

• Emerging Policy Signals Shaping Pharmaceutical Policy

August 2026

• The Expanding, Interwoven Objectives of Pharmaceutical Policy